Electrophysiology Dystonia D2 dopamine receptor Medium Spiny neurons Fast-spiking interneuron DYT1 dystonia is caused by a deletion in a glutamic acid residue in the C-terminus of the protein torsinA, whose function is still largely unknown. Alterations in GABAergic signaling have been involved in the pathogenesis of dystonia. We recorded GABA-and glutamate-mediated synaptic currents from a striatal slice preparation obtained from a mouse model of DYT1 dystonia. In medium spiny neurons (MSNs) from mice expressing human mutant torsinA (hMT), we observed a significantly higher frequency, but not amplitude, of GABAergic spontaneous inhibitory postsynaptic currents (sIPSCs) and miniature currents (mIPSCs), whereas glutamate-dependent spontaneous excitatory synaptic currents (sEPSCs) were normal. No alterations were found in mice overexpressing normal human torsinA (hWT). To identify the possible sources of the increased GABAergic tone, we recorded GABAergic Fast-Spiking (FS) interneurons that exert a feed-forward inhibition on MSNs. However, both sEPSC and sIPSC recorded from hMT FS interneurons were comparable to hWT and non-transgenic (NT) mice. In physiological conditions, dopamine (DA) D2 receptor act presynaptically to reduce striatal GABA release. Of note, application of the D2-like receptor agonist quinpirole failed to reduce the frequency of sIPSCs in MSNs from hMT as compared to hWT and NT mice. Likewise, the inhibitory effect of quinpirole was lost on evoked IPSCs both in MSNs and FS interneurons from hMT mice. Our findings demonstrate a disinhibition of striatal GABAergic synaptic activity, that can be at least partially attributed to a D2 DA receptor dysfunction.
Introduction
DYT1 dystonia is a severe form of inherited generalized dystonia, caused by a deletion in the DYT1 gene encoding the protein torsinA (Ozelius et al., 1997) . The physiological function of torsinA is unclear, though it has been proposed to perform chaperone-like functions, assist in protein trafficking, membrane fusion and participate in secretory processing (Goodchild et al., 2005; Granata et al., 2007; Hewett et al., 2007) . The neurochemical basis for primary dystonia is currently unknown, although abnormalities in striatal dopaminergic signalling have been proposed to play a role in the pathophysiology of this disorder (rev. Breakefield, et al., 2008) . A reduction of dopamine (DA) levels was found in the putamen and caudate in one DYT1 patient (Furukawa et al., 2000) . A subsequent study revealed no difference in total striatal DA content in three DYT1 brains, but an increased DOPAC/ DA ratio, suggestive of an increased DA turnover, along with a trend toward decreased D1 and D2 receptor binding (Augood et al., 2002) . In non-manifesting carriers of the DYT1 mutation, a PET study revealed a moderate reduction of striatal D2 receptor binding (Asanuma et al., 2005) . Similar results have been reported in patients with focal dystonia (Perlmutter et al., 1997) .
Evidence on the role of DA transmission emerged also from genetic mouse models of DYT1 dystonia. In mice overexpressing mutant torsinA (Sharma et al., 2005) , basal striatal DA levels and binding of D1 and D2 receptors were unaffected (Balcioglu et al., 2007; Zhao et al., 2008) . However, amphetamine-induced DA release was reduced. DA metabolite ratios were found either increased (Zhao et al., 2008 ), or unchanged (Balcioglu et al., 2007 . In this same model, we have identified altered D2 receptor responses in striatal cholinergic interneurons (Pisani et al., 2006) . Recently, abnormalities in serotonin, but not DA levels were found in another model of DYT1 dystonia (Grundmann et al., 2007) .
GABAergic medium spiny neurons (MSNs) are the principal output neurons and the primary target of the dopaminergic nigrostriatal 
